Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Experimental Neurology|May 12, 2009
Absence of striatal newborn neurons with mature phenotype following defined striatal and cortical excitotoxic brain injuriesTomas Deierborg, Karin Staflin, Jelena Pesic, et al.
Elife|April 18, 2024
Inhibition of the serine protease HtrA1 by SerpinE2 suggests an extracellular proteolytic pathway in the control of neural crest migrationEdgar M Pera, Josefine Nilsson-De Moura, Yuriy Pomeshchik, et al.
Frontiers in Neuroanatomy|October 30, 2008
Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cellsAna Sofia Correia, Sergey V Anisimov, Laurent Roybon, et al.
Plos One|March 11, 2009
Neurogenin2 directs granule neuroblast production and amplification while NeuroD1 specifies neuronal fate during hippocampal neurogenesisLaurent Roybon, Tord Hjalt, Simon Stott, et al.
Brain : a Journal of Neurology|December 19, 2014
Genetic manipulation of adult-born hippocampal neurons rescues memory in a mouse model of Alzheimer's diseaseKevin Richetin, Clémence Leclerc, Nicolas Toni, et al.
Stem Cell Research|January 16, 2018
Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's diseaseEkaterina Savchenko, Ana Marote, Kaspar Russ, et al.
Stem Cell Research|January 15, 2018
Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutationKaspar Russ, Ana Marote, Ekaterina Savchenko, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 22, 2009
GABAergic differentiation induced by Mash1 is compromised by the bHLH proteins Neurogenin2, NeuroD1, and NeuroD2Laurent Roybon, Teresa L Mastracci, Diogo Ribeiro, et al.
Biochimie|May 29, 2003
Recognition of cell surface acceptors by two human alpha-2,6-sialyltransferases produced in CHO cellsSandrine Donadio, Christophe Dubois, Gwennaele Fichant, et al.
Stem Cell Research|January 19, 2020
Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA geneCarla Azevedo, Margarita Chumarina, Evgenija Serafimova, et al.
Pageof 7